Firma Ksilink, Autor bei PR-Web

Arrhythmogenic Cardiomyopathy

Posted on 12. October 202317. October 2023 by Firma Ksilink Posted in General Tagged ACM, calore, cardiac, clinical, discovery, disease, ksilink, new, patients, project, registry, research, therapy, treatment, with

The research project, named IMPACT – Cardiogenomics meets Artificial Intelligence: a step forward in arrhythmogenic cardiomyopathy diagnosis and treatment – will run for 36 months and has been funded with 4 million euros by the European Innovation Council for cardiogenomics. […]

environMENTAL – New EU-Funded project reveals the role of environMENTAL factors for mental illnesses

Posted on 7. September 2022 by Firma Ksilink Posted in General Tagged Big Data, climate change, corona, covid, environment, europe, ksilink, mental disorders, psychiatric disorders, urbanisation

The EU-funded project environMENTAL is holding its kick-off meeting to initiate its investigation on the influence of global environmental challenges on brain and mental health. The international consortium led by Prof. Gunter Schumann, Head of the Centre for Population Neuroscience and Stratified […]

Myrtil Biotechnologies – innovating drug discovery for patients with dilated cardiomyopathy

Posted on 7. July 20227. July 2022 by Firma Ksilink Posted in General Tagged artificial intelligence, dilated cardiomyopathy, disease model, drug discovery, image analysis, ksilink, machine learning, myriamed, patient, pehnotypic screening, rare disease, titin, ttn

In a long-term collaboration, Ksilink and myriamed jointly established and validated an induced pluripotent stem cell (iPSC)-derived model of dilated cardiomyopathy (DCM), which will now be exploited by the newly created joint venture ‘Myrtil Biotechnologies’. DCM is a life-threatening disease […]

Ksilink, joining academic-industry cell imaging consortium

Posted on 21. July 202020. August 2020 by Firma Ksilink Posted in General Tagged artificial intelligence, cellular assay, cooperation, drug discovery, HTS-HCS, innovation, patient, phenotypic screening

The Joint Undertaking in Morphological Profiling with Cell Painting aims to accelerate drug discovery and development by creating a massive dataset of cells imaged under more than 140,000 different conditions. The public-private translational center Ksilink together with industry and non-profit […]